Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HuMax-CD4 in Early Stage CTCL
NCT00071071Phase 2Completed
- Sponsor
- Genmab
- Start
- Apr 2003
- Primary completion
- May 2004
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of zanolimumab in cutaneous T-cell lymphoma (CTCL), sponsored by Genmab. Started Apr 2003; status: completed.
02
Drugs
zanolimumab
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT00071071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00071071.